CHIEF-PD trial

The CHIEF-PD trial is looking to determine if a certain medication can help prevent falls in people with Parkinson’s Disease.

Falls are a common complication of Parkinson’s and can lead to injuries and reduced confidence when walking.  Previous trials have highlighted that drugs called cholinesterase inhibitors, used to treat dementia and memory problems, can help make walking steadier and therefore reduce the number of falls people experience.

This study is being carried out by researchers from the University of Bristol and is funded by Royal United Hospitals Bath NHS Foundation Trust.